Epithelial-to-mesenchymal transition correlates with gefitinib resistance in NSCLC cells and the liver X receptor ligand GW3965 reverses gefitinib resistance through inhibition of vimentin

Hu Y, Zang J, Qin X, Yan D, Cao H, Zhou L, Ni J, Yu S, Wu J, Feng JF

OncoTargets and Therapy 2017, 10:2341-2348

Published Date: 28 April 2017

Elevated serum levels of vascular endothelial growth factor predict a poor prognosis of platinum-based chemotherapy in non-small cell lung cancer

Zang JL, Hu Y, Xu XY, Ni J, Yan DL, Liu SW, He J, Xue J, Wu JZ, Feng JF

OncoTargets and Therapy 2017, 10:409-415

Published Date: 18 January 2017